IASLC Staging Handbook

Q: お住まいの国では利用できないIASLC Staging Handbookをダウンロードしたい時にはどうすればいい？

<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">ここ</a>をクリック！地理的に制限されているアプリのダウンロード方法をご参考ください。

Free

4.3.4for iPhone, iPad

Editorial Rx Press

Developer

2019年02月10日

Update Date

Medical

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

IASLC Staging Handbook スクリーンショット

iPad

iPhone

About IASLC Staging Handbook

Presents IASLC-recommended changes for lung cancer staging in the UICC and AJCC 8th edition of TNM. Includes IASLC-original illustrations, beautifully rendered specifically for the iPad and smartphone media. Especially valuable to oncologists, surgeons, radiologists, scientists, and pathologists working in the field of thoracic oncology.

It is the IASLC's hope that the 8th edition of the Staging Classification will be a useful tool for further research and will serve as a resource in the daily lung cancer clinic to benefit the many patients with lung cancer and other thoracic malignancies.

This app is sponsored by Lilly Oncology. Proceedings leading up to and culminating in the 8th edition of TNM staging classifications were funded by a grant from Eli Lilly and Company to IASLC for educational purposes only. The content is controlled and developed solely by IASLC. Lilly had no input into the proceedings or the TNM staging classifications.

Further assistance for this app is available from info@editorialrxpress.com.